Phenotypic Drug Discovery Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phenotypic Drug Discovery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Platform
1.2.3 Service
1.3 Market by Application
1.3.1 Global Phenotypic Drug Discovery Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Viral Infection
1.3.4 Genetic Disease
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Phenotypic Drug Discovery Market Perspective (2017-2028)
2.2 Phenotypic Drug Discovery Growth Trends by Region
2.2.1 Phenotypic Drug Discovery Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Phenotypic Drug Discovery Historic Market Size by Region (2017-2022)
2.2.3 Phenotypic Drug Discovery Forecasted Market Size by Region (2023-2028)
2.3 Phenotypic Drug Discovery Market Dynamics
2.3.1 Phenotypic Drug Discovery Industry Trends
2.3.2 Phenotypic Drug Discovery Market Drivers
2.3.3 Phenotypic Drug Discovery Market Challenges
2.3.4 Phenotypic Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Phenotypic Drug Discovery Players by Revenue
3.1.1 Global Top Phenotypic Drug Discovery Players by Revenue (2017-2022)
3.1.2 Global Phenotypic Drug Discovery Revenue Market Share by Players (2017-2022)
3.2 Global Phenotypic Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Phenotypic Drug Discovery Revenue
3.4 Global Phenotypic Drug Discovery Market Concentration Ratio
3.4.1 Global Phenotypic Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phenotypic Drug Discovery Revenue in 2021
3.5 Phenotypic Drug Discovery Key Players Head office and Area Served
3.6 Key Players Phenotypic Drug Discovery Product Solution and Service
3.7 Date of Enter into Phenotypic Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Phenotypic Drug Discovery Breakdown Data by Type
4.1 Global Phenotypic Drug Discovery Historic Market Size by Type (2017-2022)
4.2 Global Phenotypic Drug Discovery Forecasted Market Size by Type (2023-2028)
5 Phenotypic Drug Discovery Breakdown Data by Application
5.1 Global Phenotypic Drug Discovery Historic Market Size by Application (2017-2022)
5.2 Global Phenotypic Drug Discovery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Phenotypic Drug Discovery Market Size (2017-2028)
6.2 North America Phenotypic Drug Discovery Market Size by Country (2017-2022)
6.3 North America Phenotypic Drug Discovery Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Phenotypic Drug Discovery Market Size (2017-2028)
7.2 Europe Phenotypic Drug Discovery Market Size by Country (2017-2022)
7.3 Europe Phenotypic Drug Discovery Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Phenotypic Drug Discovery Market Size (2017-2028)
8.2 Asia-Pacific Phenotypic Drug Discovery Market Size by Country (2017-2022)
8.3 Asia-Pacific Phenotypic Drug Discovery Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Phenotypic Drug Discovery Market Size (2017-2028)
9.2 Latin America Phenotypic Drug Discovery Market Size by Country (2017-2022)
9.3 Latin America Phenotypic Drug Discovery Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Phenotypic Drug Discovery Market Size (2017-2028)
10.2 Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2017-2022)
10.3 Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Eurofins Discovery
11.1.1 Eurofins Discovery Company Detail
11.1.2 Eurofins Discovery Business Overview
11.1.3 Eurofins Discovery Phenotypic Drug Discovery Introduction
11.1.4 Eurofins Discovery Revenue in Phenotypic Drug Discovery Business (2017-2022)
11.1.5 Eurofins Discovery Recent Development
11.2 Sygnature Discovery
11.2.1 Sygnature Discovery Company Detail
11.2.2 Sygnature Discovery Business Overview
11.2.3 Sygnature Discovery Phenotypic Drug Discovery Introduction
11.2.4 Sygnature Discovery Revenue in Phenotypic Drug Discovery Business (2017-2022)
11.2.5 Sygnature Discovery Recent Development
11.3 PsychoGenics
11.3.1 PsychoGenics Company Detail
11.3.2 PsychoGenics Business Overview
11.3.3 PsychoGenics Phenotypic Drug Discovery Introduction
11.3.4 PsychoGenics Revenue in Phenotypic Drug Discovery Business (2017-2022)
11.3.5 PsychoGenics Recent Development
11.4 siTOOLs Biotech
11.4.1 siTOOLs Biotech Company Detail
11.4.2 siTOOLs Biotech Business Overview
11.4.3 siTOOLs Biotech Phenotypic Drug Discovery Introduction
11.4.4 siTOOLs Biotech Revenue in Phenotypic Drug Discovery Business (2017-2022)
11.4.5 siTOOLs Biotech Recent Development
11.5 PhoreMost
11.5.1 PhoreMost Company Detail
11.5.2 PhoreMost Business Overview
11.5.3 PhoreMost Phenotypic Drug Discovery Introduction
11.5.4 PhoreMost Revenue in Phenotypic Drug Discovery Business (2017-2022)
11.5.5 PhoreMost Recent Development
11.6 Charles River
11.6.1 Charles River Company Detail
11.6.2 Charles River Business Overview
11.6.3 Charles River Phenotypic Drug Discovery Introduction
11.6.4 Charles River Revenue in Phenotypic Drug Discovery Business (2017-2022)
11.6.5 Charles River Recent Development
11.7 MaxWell
11.7.1 MaxWell Company Detail
11.7.2 MaxWell Business Overview
11.7.3 MaxWell Phenotypic Drug Discovery Introduction
11.7.4 MaxWell Revenue in Phenotypic Drug Discovery Business (2017-2022)
11.7.5 MaxWell Recent Development
11.8 Arctoris
11.8.1 Arctoris Company Detail
11.8.2 Arctoris Business Overview
11.8.3 Arctoris Phenotypic Drug Discovery Introduction
11.8.4 Arctoris Revenue in Phenotypic Drug Discovery Business (2017-2022)
11.8.5 Arctoris Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Phenotypic Drug Discovery Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Platform
Table 3. Key Players of Service
Table 4. Global Phenotypic Drug Discovery Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Phenotypic Drug Discovery Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Phenotypic Drug Discovery Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Phenotypic Drug Discovery Market Share by Region (2017-2022)
Table 8. Global Phenotypic Drug Discovery Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Phenotypic Drug Discovery Market Share by Region (2023-2028)
Table 10. Phenotypic Drug Discovery Market Trends
Table 11. Phenotypic Drug Discovery Market Drivers
Table 12. Phenotypic Drug Discovery Market Challenges
Table 13. Phenotypic Drug Discovery Market Restraints
Table 14. Global Phenotypic Drug Discovery Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Phenotypic Drug Discovery Market Share by Players (2017-2022)
Table 16. Global Top Phenotypic Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenotypic Drug Discovery as of 2021)
Table 17. Ranking of Global Top Phenotypic Drug Discovery Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Phenotypic Drug Discovery Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Phenotypic Drug Discovery Product Solution and Service
Table 21. Date of Enter into Phenotypic Drug Discovery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Phenotypic Drug Discovery Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Phenotypic Drug Discovery Revenue Market Share by Type (2017-2022)
Table 25. Global Phenotypic Drug Discovery Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Phenotypic Drug Discovery Revenue Market Share by Type (2023-2028)
Table 27. Global Phenotypic Drug Discovery Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Phenotypic Drug Discovery Revenue Market Share by Application (2017-2022)
Table 29. Global Phenotypic Drug Discovery Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Phenotypic Drug Discovery Revenue Market Share by Application (2023-2028)
Table 31. North America Phenotypic Drug Discovery Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Phenotypic Drug Discovery Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Phenotypic Drug Discovery Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Phenotypic Drug Discovery Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Phenotypic Drug Discovery Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Phenotypic Drug Discovery Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Phenotypic Drug Discovery Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Phenotypic Drug Discovery Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2023-2028) & (US$ Million)
Table 41. Eurofins Discovery Company Detail
Table 42. Eurofins Discovery Business Overview
Table 43. Eurofins Discovery Phenotypic Drug Discovery Product
Table 44. Eurofins Discovery Revenue in Phenotypic Drug Discovery Business (2017-2022) & (US$ Million)
Table 45. Eurofins Discovery Recent Development
Table 46. Sygnature Discovery Company Detail
Table 47. Sygnature Discovery Business Overview
Table 48. Sygnature Discovery Phenotypic Drug Discovery Product
Table 49. Sygnature Discovery Revenue in Phenotypic Drug Discovery Business (2017-2022) & (US$ Million)
Table 50. Sygnature Discovery Recent Development
Table 51. PsychoGenics Company Detail
Table 52. PsychoGenics Business Overview
Table 53. PsychoGenics Phenotypic Drug Discovery Product
Table 54. PsychoGenics Revenue in Phenotypic Drug Discovery Business (2017-2022) & (US$ Million)
Table 55. PsychoGenics Recent Development
Table 56. siTOOLs Biotech Company Detail
Table 57. siTOOLs Biotech Business Overview
Table 58. siTOOLs Biotech Phenotypic Drug Discovery Product
Table 59. siTOOLs Biotech Revenue in Phenotypic Drug Discovery Business (2017-2022) & (US$ Million)
Table 60. siTOOLs Biotech Recent Development
Table 61. PhoreMost Company Detail
Table 62. PhoreMost Business Overview
Table 63. PhoreMost Phenotypic Drug Discovery Product
Table 64. PhoreMost Revenue in Phenotypic Drug Discovery Business (2017-2022) & (US$ Million)
Table 65. PhoreMost Recent Development
Table 66. Charles River Company Detail
Table 67. Charles River Business Overview
Table 68. Charles River Phenotypic Drug Discovery Product
Table 69. Charles River Revenue in Phenotypic Drug Discovery Business (2017-2022) & (US$ Million)
Table 70. Charles River Recent Development
Table 71. MaxWell Company Detail
Table 72. MaxWell Business Overview
Table 73. MaxWell Phenotypic Drug Discovery Product
Table 74. MaxWell Revenue in Phenotypic Drug Discovery Business (2017-2022) & (US$ Million)
Table 75. MaxWell Recent Development
Table 76. Arctoris Company Detail
Table 77. Arctoris Business Overview
Table 78. Arctoris Phenotypic Drug Discovery Product
Table 79. Arctoris Revenue in Phenotypic Drug Discovery Business (2017-2022) & (US$ Million)
Table 80. Arctoris Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Phenotypic Drug Discovery Market Share by Type: 2021 VS 2028
Figure 2. Platform Features
Figure 3. Service Features
Figure 4. Global Phenotypic Drug Discovery Market Share by Application in 2021 & 2028
Figure 5. Cancer Case Studies
Figure 6. Viral Infection Case Studies
Figure 7. Genetic Disease Case Studies
Figure 8. Others Case Studies
Figure 9. Phenotypic Drug Discovery Report Years Considered
Figure 10. Global Phenotypic Drug Discovery Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Phenotypic Drug Discovery Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Phenotypic Drug Discovery Market Share by Region: 2021 VS 2028
Figure 13. Global Phenotypic Drug Discovery Market Share by Players in 2021
Figure 14. Global Top Phenotypic Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenotypic Drug Discovery as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Phenotypic Drug Discovery Revenue in 2021
Figure 16. North America Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Phenotypic Drug Discovery Market Share by Country (2017-2028)
Figure 18. United States Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Phenotypic Drug Discovery Market Share by Country (2017-2028)
Figure 22. Germany Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Phenotypic Drug Discovery Market Share by Region (2017-2028)
Figure 30. China Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Phenotypic Drug Discovery Market Share by Country (2017-2028)
Figure 38. Mexico Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Phenotypic Drug Discovery Market Share by Country (2017-2028)
Figure 42. Turkey Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Phenotypic Drug Discovery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Eurofins Discovery Revenue Growth Rate in Phenotypic Drug Discovery Business (2017-2022)
Figure 45. Sygnature Discovery Revenue Growth Rate in Phenotypic Drug Discovery Business (2017-2022)
Figure 46. PsychoGenics Revenue Growth Rate in Phenotypic Drug Discovery Business (2017-2022)
Figure 47. siTOOLs Biotech Revenue Growth Rate in Phenotypic Drug Discovery Business (2017-2022)
Figure 48. PhoreMost Revenue Growth Rate in Phenotypic Drug Discovery Business (2017-2022)
Figure 49. Charles River Revenue Growth Rate in Phenotypic Drug Discovery Business (2017-2022)
Figure 50. MaxWell Revenue Growth Rate in Phenotypic Drug Discovery Business (2017-2022)
Figure 51. Arctoris Revenue Growth Rate in Phenotypic Drug Discovery Business (2017-2022)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
